search
Back to results

Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1 (EHOSS-1)

Primary Purpose

Septic Shock

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
FLUID MANAGEMENT GUIDED WITH PRELOAD-DEPENDENCE PARAMETERS (VOLUVEN ®)
STANDARD-GUIDED FLUID MANAGEMENT (VOLUVEN ®)
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Septic Shock focused on measuring Septic shock, Randomized controlled trial, Preload dependence, Pulmonary thermodilution

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age over 18 years
  • and fulfilment of two of four criteria for the systemic inflammatory response syndrome
  • and systolic blood pressure no higher than 90 mm Hg (after a crystalloid-fluid challenge of 25 ml per kilogram of body weight over a 30-minute period)
  • and documented or suspected infection

Exclusion Criteria:

  • delay between first observation of hypotension and inclusion above 12 hours
  • pregnancy
  • acute coronary syndrome
  • acute cerebral vascular event (< 1 month),
  • contraindication to central venous catheterization in the superior vena cava territory
  • contraindication to femoral arterial catheterization
  • active haemorrhage
  • burn injury
  • trauma
  • requirement for immediate surgery (< 6 hours)
  • acute pulmonary oedema of cardiogenic origin
  • do-not-resuscitate status, or advanced directives restricting implementation of the protocol.
  • Informed consent not obtained from the patient or surrogates
  • Patient already included in another therapeutic trial
  • patient previously included in the same therapeutic trial

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    PRELOAD DEPENDENCE

    CONTROL

    Arm Description

    in this arm, fluid loading is administered with an algorithm using preload dependence indexes (variation in cardiac output in response to passive leg raising).

    Outcomes

    Primary Outcome Measures

    Time to septic shock resolution
    shock resolution is defined by vasopressor weaning

    Secondary Outcome Measures

    mortality
    Ventilator free days
    number of days with hyperlactactatemia
    number of days with pulmonary edema
    assessed by transpulmonary thermodilution

    Full Information

    First Posted
    October 11, 2013
    Last Updated
    October 30, 2013
    Sponsor
    Hospices Civils de Lyon
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01972828
    Brief Title
    Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1
    Acronym
    EHOSS-1
    Official Title
    Effect of Haemodynamic Optimization Using Preload Dependence Indexes and Pulmonary Thermodilution on Cardiovascular Failure Duration During Septic Shock: a Randomized Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2013
    Overall Recruitment Status
    Completed
    Study Start Date
    July 2007 (undefined)
    Primary Completion Date
    August 2013 (Actual)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Hospices Civils de Lyon

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Haemodynamic optimization is of paramount importance in septic shock, but is really consensual and standardized during the first 6 hours of treatment. Haemodynamic treatment including fluid loading management, vasoactive treatment and oxygen transport optimization is mainly based on expert recommendations or non-randomized trials. Recently, preload dependence indexes such as pulse pressure variation have been shown to be more accurate to predict fluid responsiveness than static indexes such as filling pressures. However, whether using preload dependence indexes changes septic shock prognostic remains to date unknown. The aim of this non-blinded randomized controlled trial is to assess whether haemodynamic optimization using preload dependence indexes and pulmonary thermodilution 1. reduces septic shock duration assessed by administration duration of vasoactive treatment (primary end point), 2. reduces regional hypoperfusion assessed by arterial lactate, 3. reduces lung hydrostatic oedema linked to excessive fluid loading (assessed by PaO2/FIO2 ratio and extravascular lung water). 4. reduces organ dysfunction (assessed by the SOFA score), ICU stay and 7 and 28 day mortality Control group is managed with an algorithm using filling pressures to drive haemodynamic treatment.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Septic Shock
    Keywords
    Septic shock, Randomized controlled trial, Preload dependence, Pulmonary thermodilution

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    61 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    PRELOAD DEPENDENCE
    Arm Type
    Experimental
    Arm Description
    in this arm, fluid loading is administered with an algorithm using preload dependence indexes (variation in cardiac output in response to passive leg raising).
    Arm Title
    CONTROL
    Arm Type
    Active Comparator
    Intervention Type
    Drug
    Intervention Name(s)
    FLUID MANAGEMENT GUIDED WITH PRELOAD-DEPENDENCE PARAMETERS (VOLUVEN ®)
    Other Intervention Name(s)
    Drug : ringer lactate, 0.9% saline, VOLUVEN ®, Procedure: haemodynamic algorithm (see below)
    Intervention Description
    in this arm, fluid loading is administered with an algorithm using preload dependence indexes. This algorithm is used every hour during the first 6 hours after inclusion, then every 4 hours until vasopressor weaning, and whenever mean arterial pressure fell below 65 mm Hg. Fluid loading is performed with cristalloids or colloids at the discretion of the attending physician.
    Intervention Type
    Drug
    Intervention Name(s)
    STANDARD-GUIDED FLUID MANAGEMENT (VOLUVEN ®)
    Other Intervention Name(s)
    Drug : ringer lactate, 0.9% saline, VOLUVEN ®, Procedure: haemodynamic algorithm (see below)
    Intervention Description
    in this arm, fluid loading is administered with an algorithm using central venous pressure. This algorithm is used every hour during the first 6 hours after inclusion, then every 4 hours until vasopressor weaning, and whenever mean arterial pressure fell below 65 mm Hg. Fluid loading is performed with cristalloids or colloids at the discretion of the attending physician.
    Primary Outcome Measure Information:
    Title
    Time to septic shock resolution
    Description
    shock resolution is defined by vasopressor weaning
    Time Frame
    28 days
    Secondary Outcome Measure Information:
    Title
    mortality
    Time Frame
    28 days
    Title
    Ventilator free days
    Time Frame
    28 days
    Title
    number of days with hyperlactactatemia
    Time Frame
    28 days
    Title
    number of days with pulmonary edema
    Description
    assessed by transpulmonary thermodilution
    Time Frame
    28 jours

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: age over 18 years and fulfilment of two of four criteria for the systemic inflammatory response syndrome and systolic blood pressure no higher than 90 mm Hg (after a crystalloid-fluid challenge of 25 ml per kilogram of body weight over a 30-minute period) and documented or suspected infection Exclusion Criteria: delay between first observation of hypotension and inclusion above 12 hours pregnancy acute coronary syndrome acute cerebral vascular event (< 1 month), contraindication to central venous catheterization in the superior vena cava territory contraindication to femoral arterial catheterization active haemorrhage burn injury trauma requirement for immediate surgery (< 6 hours) acute pulmonary oedema of cardiogenic origin do-not-resuscitate status, or advanced directives restricting implementation of the protocol. Informed consent not obtained from the patient or surrogates Patient already included in another therapeutic trial patient previously included in the same therapeutic trial

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    25572383
    Citation
    Richard JC, Bayle F, Bourdin G, Leray V, Debord S, Delannoy B, Stoian AC, Wallet F, Yonis H, Guerin C. Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial. Crit Care. 2015 Jan 8;19(1):5. doi: 10.1186/s13054-014-0734-3.
    Results Reference
    derived

    Learn more about this trial

    Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1

    We'll reach out to this number within 24 hrs